Rite Aid (RAD) Is Facing More Reimbursement Pressure - Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst, Robert Jones, reiterated his Sell rating on shares of Rite-Aid (NYSE: RAD) after the company reported a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


